November 17th, 2026Precision Medicine Equity Hinges on Systems, but Coverage Gaps Linger Panelists concurred that precision medicine can serve to exacerbate care inequality if not everyone can access these therapeutics. Read more
November 20th, 2026Health Equity & Access Weekly Roundup: November 20, 2026Employer diabetes guide; Camden psychedelic therapy input; CRC after EMR; rural HFrEF care; JAMA obesity report.Read more
November 19th, 2026Most Patients With Psoriasis Screened Positive for PsA at One Dermatology ClinicIn a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.Read more
November 18th, 2026Hepatitis B Screening Gaps Persist as Functional Cure Option ArrivesNew York hepatitis B experts say screening gaps and weekly monitoring demands could limit who benefits from the first functional cure therapy.Read more
November 17th, 2026Atopic Dermatitis Escalation Stalls on Payer Rules, Thin TrackingSan Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy teams and dashboards.Read more
November 17th, 2026In Psoriasis, IL-23 Inhibitors Tied to Lower PsA Risk Than JAKsIL-23 inhibitors linked to lower psoriatic arthritis risk than JAK inhibitors, and IL-17 inhibitors showed higher risk.Read more
November 20th, 2026FDA Approves Pimicotinib for Symptomatic Tenosynovial Giant Cell TumorPimicotinib, a once-daily oral CSF-1R inhibitor, is now FDA approved for adults with TGCT for whom surgery may worsen function or cause severe morbidity.Read more
November 20th, 2026Real-World Brexu-cel Results in MCL Mirror Trials; Cost, QOL Data LagPooled real-world data show an 88% response rate with brexu-cel in relapsed mantle cell lymphoma (MCL), but cost and QOL data are scarce.Read more